Skip to content
Screener

BioMarin Pharmaceuticals BMRN Enterprise value

Enterprise value at other companies

Sarepta Therapeutics, Inc. logo
Sarepta Therapeutics, Inc.SRPT
$1.52B-2.9%
PTC Therapeutics logo
PTC TherapeuticsPTCT
$5.2B+77.3%
Zevra Therapeutics, Inc. logo
Zevra Therapeutics, Inc.ZVRA
$703.89M+36.7%
Agios Pharmaceuticals logo
Agios PharmaceuticalsAGIO
$2.14B+12.4%
Regenxbio logo
RegenxbioRGNX
$651.8M+51.8%
BridgeBio Pharma logo
BridgeBio PharmaBBIO
$16.77B+178%

Other financials

Income statement

See full
Revenue$989.7M+19.9%
Gross profit$786.9M+16.5%
Operating income$110.9M-59.9%
Net income$44.8M-81.4%
EPS (diluted)$0.23-81.3%

Balance sheet

See full
Cash & equivalents$874.0M-28.0%
Total debt$4.2B+598%
Total equity$6.3B+4.9%
Total assets$11.7B+57.2%

Cash flow

See full
Operating cash flow$168.1M-9.3%
CapEx$28.8M+68.5%
Free cash flow$139.3M-17.2%

Valuation

See full
Market cap$11.58B-0.6%
P/E32.2×-34.7×
P/S3.4×-0.4×

Profitability

See full
Gross margin76.1%-3.4pp
Operating margin19.9%+7.2pp
Net margin16.8%+5.1pp
FCF margin21.7%-1.0pp

Returns & leverage

See full
Return on equity9.1%+2.8pp
Debt / equity0.7×+0.6×
Current ratio2.4×-3.2×

Where this comes from

Calculated from BioMarin Pharmaceuticals’s reported figures.

$11.1Bmarket cap+$4.2Btotal debt−$874.0Mcash and equivalents=$14.37B

The source filing: BioMarin Pharmaceuticals’s 10-Q, filed August 6, 2026. Open the filing →

Filed
Aug 6, 2026, 4:14 PM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q2 2026
Accession
0001048477-26-000016

FAQ

What is BioMarin Pharmaceuticals's enterprise value?
BioMarin Pharmaceuticals (BMRN) reported enterprise value of $14.37B in Q2 2026.
How has BioMarin Pharmaceuticals's enterprise value changed year-over-year?
BioMarin Pharmaceuticals's enterprise value increased by 45.5% year-over-year, from $9.87B to $14.37B.
What is the long-term trend for BioMarin Pharmaceuticals's enterprise value?
Over 5 years (2020 to 2025), BioMarin Pharmaceuticals's enterprise value has grown at a -7.1% compound annual growth rate (CAGR), from $15.51B to $10.75B.
What does enterprise value mean?
Market capitalization plus total debt minus cash, at the quarter end. The cost to acquire the whole business — what an buyer pays for equity and debt, net of the cash they'd inherit.

Ask your AI about BioMarin Pharmaceuticals's enterprise value.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude